3Analytics
3Analytics is an AI-driven pharmacovigilance SaaS platform serving pharmaceutical, medical device, vaccine, and cosmetics companies. Its proprietary ADR/AE Analytics Engine powers signal management, literature monitoring, regulatory intelligence, and IMDRF coding solutions globally.
- Company typePrivate
- Founded2020
- HeadquartersCupertino, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What 3Analytics does
3Analytics is a privately held AI-driven pharmacovigilance and safety analytics company founded in January 2020 in Silicon Valley, California, with operational headquarters in Frisco, Texas and a wholly-owned India subsidiary (3Analytics India Private Limited) in Chennai. The company operates a GxP-compliant, cloud-based SaaS platform built on a proprietary ADR/AE Analytics Engine that combines natural language processing across 100+ languages, machine learning, and statistical signal detection (including PRR, ROR, IC, regression models, and Tree Scan Statistics) to address safety monitoring for drugs, medical devices, vaccines, biologics, and cosmetics.
Its commercial product suite comprises four core modules: Signals (AI-powered signal management), Bio-Med Literature (automated ICSR extraction from medical literature), RegIntel (regulatory intelligence across 100+ countries with the Luna AI assistant), and an IMDRF Automated Coding Solution (95% claimed accuracy, 72% cost reduction). The company cites regulatory validation through a WHO shortlisting for active vaccine safety surveillance and a strategic partnership with JHPIEGO (Johns Hopkins Public Health Affiliate), alongside an enterprise GTM partnership with AssurX announced in 2025.
3Analytics monetizes primarily through annual SaaS subscriptions on a quote-based enterprise pricing model, supplemented by professional services for implementation and customization. It sells through direct enterprise field sales led by a VP of Sales with 25+ years of healthcare software experience, supported by educational webinars, content marketing, and channel partnerships. The disclosed customer base is concentrated in pharmaceutical companies, medical device manufacturers, vaccine producers, and public health organizations, with named enterprise references in pharma and medical devices.
3Analytics firmographics
Firmographics- Name
- 3Analytics
- Legal name
- 3Analytics India Private Limited
- Website
- https://3analytics.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- 3Analytics is an AI-driven pharmacovigilance SaaS platform serving pharmaceutical, medical device, vaccine, and cosmetics companies. Its proprietary ADR/AE Analytics Engine powers signal management, literature monitoring, regulatory intelligence, and IMDRF coding solutions globally.
- Ownership category
- akta.pro rank
3Analytics industry classification
Industry- Product category
- Pharmacovigilance Software
- NAICS
- Software Publishers (5132), Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industries
- Signal Detection & Safety Analytics (Epidemiology/RWE) (HLAGALAC), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)
Keywords
Where 3Analytics is headquartered
LocationHeadquarters
- HQ city
- Cupertino
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
3Analytics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS Platform Subscription: Cloud-based software-as-a-service platform providing pharmacovigilance and regulatory compliance solutions. Subscription-based model with tiered offerings for signal management, literature monitoring, regulatory intelligence, and IMDRF coding
- Professional Services: Implementation, customization, and consulting services for tailoring AI-driven solutions to unique customer needs
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise solutions with customized pricing |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
3Analytics product offering
Product offeringCore offering
3Analytics sells a cloud-based, AI/ML/NLP-driven pharmacovigilance SaaS platform that helps pharmaceutical, medical device, vaccine, and cosmetics organizations detect safety signals, automate literature monitoring and ICSR extraction, manage regulatory intelligence across 100+ countries, and code medical device complaints using IMDRF standards. The platform is built on a proprietary ADR/AE Analytics Engine and is delivered primarily via enterprise subscriptions with associated professional services for implementation and customization.
Product overview
3Analytics offers a platform-plus-modules architecture built on its proprietary ADR/AE Analytics Engine. The product suite comprises four core modules: Signals (AI-powered signal management platform), Bio-Med Literature (automated literature monitoring and ICSR extraction), RegIntel (global regulatory intelligence), and IMDRF (automated medical device complaint coding). These integrated solutions share the common analytics engine and collectively address drug safety, medical device vigilance, vaccine pharmacovigilance, and cosmetovigilance, enabling end-to-end compliance management from signal detection through regulatory reporting.
Differentiator
Problem solved
Functional benefit
Brands
- Signals: AI-driven Signal Management platform for drug, device, and vaccine safety signal detection and compliance.
- Bio-Med Literature
- IMDRF Coding Solution
- RegIntel
- Luna
Products and services
- Signals (Signal Management Platform) AI-powered platform for detecting, validating, and managing safety signals for drugs, devices, and vaccines, combining qualitative and quantitative analytics with 20+ advanced algorithms (PRR, ROR, IC, regression models, Tree Scan Statistics), real-time detection, workflow automation, and audit-ready compliance reporting.
- Bio-Med Literature Platform Automated literature monitoring platform that identifies Individual Case Safety Reports (ICSRs) from medical and scientific literature, with AI-powered ICSR extraction, duplicate detection, multi-language support in 100+ languages, and E2B R3 compliant export for safety databases and regulatory submissions.
- RegIntel (Regulatory Intelligence Platform) Global regulatory intelligence platform providing real-time updates on regulatory requirements across 100+ countries, featuring the Luna AI assistant for instant regulatory queries, tailored reporting for Biologics, Drugs, Medical Devices, and Vaccines, and visualization dashboards covering Clinical Trial, Pre-Marketing, and Post-Marketing stages.
- IMDRF (Automated Coding Solution) AI-driven IMDRF coding solution for medical device complaint management that automates real-time complaint coding, handles multiple allegations per complaint, and ensures compliance with EU MDR and FDA guidelines, integrating with QMS and achieving up to 72% cost reduction with documented 95% accuracy.
Quantifiable outcome
- 95% AI coding accuracy for IMDRF medical device complaint processing
- +3 more outcomes
Companies that use 3Analytics
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
3Analytics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature6 records
3Analytics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- AssurXflagshipPartnership webinar on Predictive Intelligence for Medical Device Safety in Post-Market Surveillance. Joint event to demonstrate integrated solutions for proactive safety management, combining data from MAUDE, complaints, QMS, and real-world evidence
- JHPIEGO (Johns Hopkins Public Health Affiliate)coreStrategic partnership with JHPIEGO, a Johns Hopkins Public Health Affiliate, positioning 3Analytics as a trailblazer in integrating pharmacovigilance with public health initiatives
- World Health Organization (WHO)coreShortlisted by WHO for active vaccine safety surveillance, demonstrating recognition of the company's capabilities in vaccine pharmacovigilance and public health technology
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
3Analytics competitors and assessment
Company assessmentDirect peers
- Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is the dominant pharmacovigilance safety database platform used by the majority of large pharmaceutical companies. It directly competes with 3Analytics' Signals platform in ICSR management, signal detection, and regulatory reporting workflows.
- Veeva Systems (Vault Safety): Veeva Vault Safety is a cloud-native pharmacovigilance suite used across life sciences for case management and signal detection. It competes with 3Analytics across the same PV workflow and increasingly serves medical device and vaccine manufacturers.
- ArisGlobal (LifeSphere): ArisGlobal's LifeSphere Safety platform offers pharmacovigilance, signal management, and regulatory intelligence for life sciences companies. It is a direct competitor to 3Analytics' Signals and RegIntel offerings across drug, device, and vaccine safety.
- Insife: Insife provides pharmacovigilance and signal management software (HALOPV) focused on AI-driven safety analytics for pharma and device manufacturers. It is a direct niche competitor to 3Analytics' Signals platform with similar AI and signal detection capabilities.
- AB Cube: AB Cube (now part of Veeva) offers safety database solutions including E2B gateway and pharmacovigilance platforms. It is a direct competitor in the case management and safety reporting space relevant to 3Analytics' Bio-Med Literature and Signals modules.
- Instem (BioClin): Instem's BioClin division provides pharmacovigilance, signal detection, and literature monitoring software for life sciences. It is a direct competitor to 3Analytics' Bio-Med Literature and signal management offerings.
Broad incumbents
- IQVIA (Safety & Regulatory): IQVIA offers pharmacovigilance and safety analytics as part of a broader technology and services portfolio spanning clinical, real-world evidence, and commercial. It overlaps with 3Analytics in signal detection and safety analytics but also bundles CRO-scale services.
Others
- Cognizant Life Sciences: Cognizant delivers pharmacovigilance services and AI-enabled safety platforms for pharma and device companies. It competes for the same enterprise PV budgets and increasingly bundles signal detection and literature monitoring capabilities similar to 3Analytics.
Emerging players
- Saama Technologies: Saama applies AI and data analytics across clinical development, regulatory, and safety workflows for life sciences. It overlaps with 3Analytics in AI-driven safety and regulatory intelligence and represents an emerging AI-native competitor.
- AssurX: AssurX provides quality management and complaint handling software for medical device manufacturers. 3Analytics co-presented a webinar with AssurX in 2025 on predictive intelligence for medical device safety, indicating adjacent offering overlap in IMDRF coding and post-market surveillance.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
3Analytics social profiles
Digital presence3Analytics compliance and trust
Trust signalCompliance3 records
3Analytics financial estimates
Financial estimateRevenue estimate
Valuation estimate
3Analytics leadership team
Management profileNumber of profiles
Profiles14 records
3Analytics subsidiaries and ownership
Company hierarchySubsidiaries1 record
3Analytics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
3Analytics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 3Analytics
What does 3Analytics do?
3Analytics sells a cloud-based, AI/ML/NLP-driven pharmacovigilance SaaS platform that helps pharmaceutical, medical device, vaccine, and cosmetics organizations detect safety signals, automate literature monitoring and ICSR extraction, manage regulatory intelligence across 100+ countries, and code medical device complaints using IMDRF standards. The platform is built on a proprietary ADR/AE Analytics Engine and is delivered primarily via enterprise subscriptions with associated professional services for implementation and customization.
Is 3Analytics a public or private company?
3Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was 3Analytics founded?
3Analytics was founded in 2020. It employs 51 to 100 people.
Where is 3Analytics based?
3Analytics is headquartered in Cupertino, United States, in the North America region.
How does 3Analytics make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services.
Who are 3Analytics's main competitors?
Direct peers on record are Oracle Health Sciences (Argus Safety), Veeva Systems (Vault Safety), ArisGlobal (LifeSphere), Insife, AB Cube and Instem (BioClin). IQVIA (Safety & Regulatory) is listed as a broad incumbent. Cognizant Life Sciences is listed as an others. Emerging players are Saama Technologies and AssurX.
Does 3Analytics have an API?
No public API is recorded for 3Analytics.
What industry is 3Analytics in?
3Analytics's product category is Pharmacovigilance Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGALAC, Signal Detection & Safety Analytics (Epidemiology/RWE). Its NAICS code is 5132 and its SIC code is 7372.